TY - JOUR T1 - Is it time for recommendations to reflect reality in PSC surveillance? JF - Frontline Gastroenterology JO - Frontline Gastroenterol SP - 88 LP - 89 DO - 10.1136/flgastro-2021-101812 VL - 13 IS - 1 AU - James Hawken AU - Gautham Appanna AU - A J Portal Y1 - 2022/01/01 UR - http://fg.bmj.com/content/13/1/88.abstract N2 - We write in response to Nicoletti et al’s Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis 1 in the January 2021 edition of Frontline Gastroenterology and the 2019 British Society of Gastroenterology (BSG) guideline it draws on.2 Guidelines often fall short of recommending surveillance for cholangiocarcinoma (CCA) in primary sclerosing cholangitis (PSC), but this seems at odds with what many hepatologists actually do due to fear of patients developing CCA and a diagnosis coming too late. It is likely that surveillance strategies vary at both regional and local level.The risk of hepatobiliary cancer is … ER -